Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.72 CAD | +4.17% | +0.52% | -0.63% |
Sales 2024 * | 670M 492M | Sales 2025 * | 710M 521M | Capitalization | 1.62B 1.19B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.4 x |
Net cash position 2024 * | 10M 7.35M | Net cash position 2025 * | 105M 77.15M | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 2,290 |
Yield 2024 * |
1.01% | Yield 2025 * |
1.28% | Free-Float | 46.48% |
Latest transcript on Andlauer Healthcare Group Inc.
1 day | +4.35% | ||
1 week | +0.69% | ||
Current month | -2.21% | ||
1 month | -3.20% | ||
3 months | +4.59% | ||
6 months | +3.14% | ||
Current year | -0.46% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
Peter Bromley
DFI | Director of Finance/CFO | 60 | 18-12-31 |
Graham Cromb
PRN | Corporate Officer/Principal | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Andlauer
CEO | Chief Executive Officer | 59 | 19-11-11 |
Director/Board Member | 51 | 19-11-11 | |
Thomas Wellner
BRD | Director/Board Member | 59 | 19-11-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.45% | 11 M€ | -.--% | ||
0.06% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 40.72 | +4.17% | 29 421 |
24-05-14 | 39.09 | +0.54% | 26,965 |
24-05-13 | 38.88 | -1.67% | 38,916 |
24-05-10 | 39.54 | -0.03% | 14,896 |
24-05-09 | 39.55 | -2.37% | 47,271 |
Delayed Quote Toronto S.E., May 15, 2024 at 12:07 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.46% | 1.18B | |
-29.26% | 70.3B | |
+2.04% | 27.46B | |
-6.73% | 17.8B | |
+2.32% | 17.46B | |
+2.05% | 15.46B | |
+6.85% | 13.49B | |
+10.80% | 13.06B | |
+70.67% | 12.96B | |
+73.46% | 12.56B |
- Stock Market
- Equities
- AND Stock